2 Dirt-Cheap High-Dividend Stocks to Buy Right Now

The S&P 500 is at its all-time high, but not all stocks are expensive. That's especially true when it comes to dividend stocks. In this video, longtime Motley Fool contributors Matt Frankel, CFP®, and Tyler Crowe discuss two of their favorite bargain-priced dividend stocks investors can buy right now.

*Stock prices used were the morning prices of Aug. 14, 2025. The video was published on Aug. 16, 2025.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

Should you invest $1,000 in Healthpeak Properties right now?

Before you buy stock in Healthpeak Properties, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Healthpeak Properties wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,115,633!*

Now, it’s worth noting Stock Advisor’s total average return is 1,077% — a market-crushing outperformance compared to 185% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of August 18, 2025

Matt Frankel has no position in any of the stocks mentioned. Tyler Crowe has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends OTC Markets Group. The Motley Fool recommends Healthpeak Properties. The Motley Fool has a disclosure policy. Matthew Frankel is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.